Vanberra Signal
Free trial

PharmEnable Therapeutics

Curated by Signal

Provider of AI-based platform for neurological drug discovery

Health Technologypharmenabletx.com

Overview

Provider of AI-based platform for neurological drug discovery. It offers AI-enabled medicinal chemistry platform chemUNIVERSE to design drug leads for neurology and oncology diseases.

Key facts

Founded
2016
Headquarters
Cambridge, United Kingdom
Stage
Sign up to view
Industry
Health Technology

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Smart Protein

    Online platform for the purchase of fitness supplements

    Health TechnologyGlasgow, United Kingdom

  • EXRT ai

    AI driven heart health monitoring device to optimize athlete health and performance

    Health TechnologyRotherham, United Kingdom

  • Active Aims

    Provider of online cloud-based platform for employee physical fitness

    Health TechnologyLoughborough, United Kingdom

About PharmEnable Therapeutics

What does PharmEnable Therapeutics do?

Provider of AI-based platform for neurological drug discovery.

Where is PharmEnable Therapeutics headquartered?

PharmEnable Therapeutics is headquartered in Cambridge, United Kingdom.

When was PharmEnable Therapeutics founded?

PharmEnable Therapeutics was founded in 2016.

Which sector is PharmEnable Therapeutics in?

PharmEnable Therapeutics operates in Health Technology.

Who are PharmEnable Therapeutics's competitors?

Companies similar to PharmEnable Therapeutics include Smart Protein, EXRT ai, and Active Aims.